InspireMD, Inc. announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluati ...
IceCure Medical Ltd. recently announced interim results from the company’s ICESECRET study of cryoablation with its ...
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, ...
Inari Medical, Inc., which is headquartered in Irvine, California, recently announced it has entered into a joint venture ...
Balt, Inc., developer of the investigational Squid liquid embolic, recently announced the publication of STEM—the Squid t ...
University Hospitals (UH) in Cleveland, Ohio, recently announced it was awarded $7 million in research funding by the Patient-C ...
Viz.ai announced new clinical data showing positive outcomes with real-world impact of the company’s technology in clinic ...
The Council of the European Union (EU) recently announced it is calling for more robust efforts to help prevent cardiovascular ...
Centerline Biomedical, Inc. announced that the company received FDA 510(k) clearance for its IOPS intra-operative positioning ...
Fluidx Medical Technology, Inc. announced that the first patient has been treated in the prospective, multinational, clinical ...
Inari Medical, Inc. announced that it has received national reimbursement approval from the Japanese Ministry of Health, ...
Route 92 Medical, Inc. recently announced that its line of neurovascular intervention products has received CE Mark approval un ...